Previous 10 | Next 10 |
Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the launch of an underwritten public offering. Dawson James Securities, Inc. is acting as sole book-running manager for the o...
AditxtScore™ will be used for Assessing Immune Status for COVID-19 Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company that improves the health of the immune system, announced today that the Johnson...
Gainers: Altamira (NASDAQ:CYTO) +68%. Wunong (NASDAQ:WNW) +52%. Everspin Technologies (NASDAQ:MRAM) +44%. SOC Telemed (NASDAQ:TLMD) +33%. Bit Brother (NASDAQ:BTB) +31%. Kura Sushi USA (NASDAQ:KRUS) +27%. Brilliant Earth Group (NASDAQ:BRLT) +26%. Xponential Fitness (NYSE:XPOF) +23%....
Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), has announced a webinar at 2pm ET this afternoon to discuss its earlier announcement today. All investors are invited to attend, whether professional or individual. On today’s webinar, CEO Amro Albanna will be sharing ...
Gainers: Altamira Therapeutics (NASDAQ:CYTO) +82%, SOC Telemed (NASDAQ:TLMD) +16%, Sundial Growers (NASDAQ:SNDL) +16%, Beyond Air (NASDAQ:XAIR) +15%, IM Cannabis (NASDAQ:IMCC) +13%. Losers: Oncorus (NASDAQ:ONCR) -43%, Acutus Medical (NASD...
Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that the global Phase 3 PRESECO (PREventing SEvere COVID-19) trial evaluating oral Avigan®/Reeqonus™ (favipiravir...
Aditxt (NASDAQ:ADTX) announces a partnership with CLX Health, a developer of cloud-based solutions. The goal of the partnership is to accelerate the market availability of AditxtScore for COVID-19 through CLX Health’s TrustAssure Solution Suite. Aditxt will be ...
Access to over 5,000 U.S. Locations Reaching 15,000 Locations Globally in over 81 countries worldwide Service to dozens of airlines that enter over 75 countries Aditxt, Inc. (Nasdaq: ADTX), (“Aditxt” or the “Company”) a bio...
Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the closing of its previously announced underwritten public offering of 2,833,333 shares of its common stock at a public offering...
Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the Company’s Co-Founder, Chairman, and CEO Amro Albanna will present at the Dawson J...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...